Delivery Order SPE2DB25D3002-SPE2DB25FLRBG
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,871.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a $20,172.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- The Defense Logistics Agency awarded a $366,740 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,440 units of HAVRIX vaccine in pre-filled syringes. The single-day contract has a period of performance from September 5-6, 2023, with all work taking place at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided on the original solicitation or whether this delivery order falls under an existing...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,097.60, is for the supply of Havrix 720 unit/0.5 mL syringes, a hepatitis A vaccine. The contract is a firm fixed-price, non-set-aside arrangement, with a performance period through April 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,429.28 firm-fixed-price contract is for the supply of HAVRIX 720 Unit/0.5 mL syringes, a hepatitis A vaccine. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE, a hepatitis A vaccine, with a total ceiling value of $2,286.60. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. The contract is a firm fixed-price, delivery order contract, and does not have a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,471 to Amerisourcebergen Drug Corporation for 720 units of HAVRIX 720, a hepatitis A vaccine. The delivery order was issued under an existing prime vendor contract held by Amerisourcebergen with DLA for pharmaceutical products. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one to two days in September 2023. No subcontractors or set aside...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,828.24, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a hepatitis A vaccine. The contract is a firm fixed-price delivery order with a performance period through May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside and was...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $16,944.90 firm fixed-price delivery order is for the supply of 1,440 units of the hepatitis A vaccine HAVRIX 1,440 UNIT/ML SYRINGE. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a $962.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 720 units of HAVRIX 720, a hepatitis A vaccine. The delivery order was issued under an existing prime vendor contract vehicle and calls for Amerisourcebergen to supply the vaccines to a location in Conshohocken, Pennsylvania by July 6, 2023. As a leading provider of medical products and logistics services to the Department of Defense, Amerisourcebergen will deliver the...